SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is generating significant community buzz, with conversation centering on its robust utility as an AI agent token and recent major exchange listings. Enthusiasm is high for its potential within the Coinbase Base ecosystem, leading many to advocate for buying dips amidst some concern over its inherent volatility.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN CRYPTO is trending as its community actively builds momentum for the upcoming 4/20 cultural event, fueled by ongoing discussions around cannabis rescheduling and its vision as a "Bitcoin but way higher" token for long-term holders.

Frontier Group Holdings, Inc. engages in the provision of air transportation. The company was founded on July 5, 1994 and is headquartered in Denver, CO.

Frontier Group Holdings Inc

Frontier Group Holdings is trending as investors weigh the implications of competitor Spirit Airlines' recent second bankruptcy filing, with many anticipating ULCC will gain market share. This key development, alongside a recent CEO transition, fuels community debate regarding the future profitability and strategic positioning of ultra-low-cost carriers within the volatile airline industry.

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.

SpyGlass Pharma Inc.

SpyGlass Pharma (SGP) is trending with a surge in community interest and watchlist placements, as investors eagerly anticipate a potential move, fueled by recent analytical content circulating online.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRG Energy is trending as a major beneficiary of the AI-driven surge in power demand, driven by its significant acquisition of natural gas generation facilities and strategic partnerships to expand capacity. The community is actively debating the sustainability of its strong performance amidst market volatility, while many remain bullish on its long-term positioning within the energy sector.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Halozyme Therapeutics is trending as a German injunction against Merck's Keytruda SC bolsters optimism for substantial MDASE licensing revenue, further fueled by robust preliminary 2025/2026 financial guidance and the welcomed withdrawal of its Evotec acquisition proposal, with the community actively highlighting its perceived undervaluation.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending due to its breakthrough AI-driven autonomous lab, developed with OpenAI, which demonstrated a 40% cost reduction in cell-free protein synthesis. This has sparked community discussions about its potential as a transformative "platform business" in synthetic biology, further fueled by increased institutional interest and government initiatives in biosecurity and AI.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB Construction Holdings is gaining significant attention following news of a substantial private placement, which many in the community interpret as a strong capital infusion to drive growth and execute on its expanding pipeline of construction contracts. This development has fueled strong bullish momentum and new highs, with investors actively debating potential dilution from the offering amidst the stock's low float and recent volatility.

WorldFinancial

World Liberty Financial (WLFI) is trending due to ongoing congressional scrutiny over a significant foreign investment deal and its pursuit of a national trust banking license, sparking debate about transparency and political influence in the crypto space. The community remains sharply divided, with advocates championing WLFI's potential to revolutionize finance through its USD1 stablecoin and upcoming real-world asset tokenization, while detractors view it as a politically-linked "scam."

Cooper-Standard Holdings, Inc. engages in the manufacture of sealing and fluid handling systems, including fuel and brake delivery and fluid transfer systems. It operates through the following segments: Sealing Systems, Fluid Handling Systems, and Corporate, Eliminations and Other. The Sealing Systems segment consists of manufacturing products for interior vehicle protection, dust and noise intrusion. The Fluid Handling Systems segment includes products that help convey, connect, control, and communicate throughout the fluid systems. The Corporate, Eliminations and Other segment is for all other business activities. The company was founded in 2004 and is headquartered in Northville, MI.

Cooper-Standard Holdings Inc

Cooper-Standard Holdings is trending as Stifel reiterated its Buy rating and raised price targets, citing confidence in the company's differentiated growth and margin expansion driven by new platform wins and increased hybrid/EV content. The community is actively debating its long-term potential and undervalued status amidst its debt reduction efforts, though some voice concerns over price volatility and perceived market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Justice Department’s Antitrust Division said on Thursday that it requires broad divestitures to resolve the challenge to UnitedHealth Group Incorporated’s (UNH) planned $3.3 billion acquisition of home health and hospice services provider Amedisys Inc. (AMED).The proposed <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition">settlement</a>, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states, accounting for approximately $528 million in annual revenue. The locations are spread across Tennessee, Alabama, Georgia, South Carolina, Virginia, Pennsylvania, New York, West Virginia, and Mississippi, among others.The settlement would secure the largest divestiture of outpatient healthcare services to resolve a merger challenge by the number of facilities, the department said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/UNH">UNH</a> fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:1366/132;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_31_56_PM_png_875db7d160.webp" alt="UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1366" height="132"><figcaption>UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>Retail sentiment around <a href="https://stocktwits.com/symbol/AMED">Amedisys</a> trended in the ‘bullish’ territory, accompanied by ‘normal’ levels of retail chatter.<figure class="image"><img style="aspect-ratio:1358/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_33_41_PM_png_b432c28787.webp" alt="AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1358" height="126"><figcaption>AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the divestitures may reduce expected synergies.<stembedurl>https://stocktwits.com/Tokki_/message/624147426</stembedurl>Additionally, the department requires Amedisys to pay a $1.1 million civil penalty and train its corporate and field leadership on antitrust compliance for falsely certifying that the company had truthfully, correctly, and completely responded to the United States’ requests for documents.UNH’s Optum unit submitted a proposal to acquire Amedisys in June 2023. UNH had acquired Amedisys’s rival LHC Group earlier that year through a $5.4 billion deal. However, the U.S. Department of Justice and attorneys general from four U.S. states filed a lawsuit in November 2024 to block the acquisition.“Eliminating the competition between UnitedHealth and Amedisys would harm patients who receive home health and hospice services, insurers who contract for home health services, and nurses who provide home health and hospice services,” the department then said.While shares of UNH are down by 52% this year, AMED is up by 11%.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-gets-price-target-hike-from-wells-fargo/chrmBLTRd3a">This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies

The proposed settlement, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states.

Equity

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates

Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?

Here's Why You Should Retain AMED Stock in Your Portfolio for Now

BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?

Are Medical Stocks Lagging  Amedisys (AMED) This Year?

Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

The DOJ Is Investigating UnitedHealth. Is UNH Stock a Buy, Sell, or Hold Now?

UnitedHealth stock tanked on reports of DOJ investigation. But analysts remain uber bullish on the healthcare services giant.

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Amedisys Inc.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

AMED
Amedisys Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMED News

AMEDAmedisys Inc.